4 institutions hold shares in Enveric Biosciences Inc. (ENVB), with 2.08M shares held by insiders accounting for 8.24% while institutional investors hold 0.60% of the company’s shares. Institutions hold 0.55% of the Float.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Enveric Biosciences Inc. (NASDAQ: ENVB) is 2.58% higher on its value in year-to-date trading and has touched a low of $2.51 and a high of $21.20 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ENVB stock was last observed hovering at around $4.70 in the last trading session, with the day’s loss setting it -0.33% off its average median price target of $50.00 for the next 12 months. It is also 91.26% off the consensus price target high of $50.00 offered by 1 analysts, but current levels are 91.26% higher than the price target low of $50.00 for the same period.
Currently trading at $4.37, the stock is 2.22% and -16.29% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.68 million and changing -7.02% at the moment leaves the stock -24.22% off its SMA200. ENVB registered -15.96% loss for a year compared to 6-month loss of -32.14%. The firm has a 50-day simple moving average (SMA 50) of $4.2675 and a 200-day simple moving average (SMA200) of $5.3318.
The stock witnessed a 7.90% gain in the last 1 month and extending the period to 3 months gives it a -13.29%, and is -10.27% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.00% over the week and 11.51% over the month.
Enveric Biosciences Inc. (ENVB) has around 397 employees, a market worth around $86.22M and $35.40M in sales. Profit margin for the company is -20.60%. Distance from 52-week low is 74.41% and -79.39% from its 52-week high. The company has generated returns on investments over the last 12 months (-43.30%).
Enveric Biosciences Inc. (ENVB) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Enveric Biosciences Inc. (ENVB) is a “Buy”. 1 analysts offering their recommendations for the stock, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Enveric Biosciences Inc. quarterly earnings per share for the current quarter are estimated at $0.The EPS is expected to grow by 86.20% this year.